BIOXCEL THERAPEUTICS INC COM NEW

BIOXCEL THERAPEUTICS INC COM NEW is a security (CUSIP 09075P204) tracked across SEC portfolio filings. 41 institutional managers reported $7.4M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $271K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 41 managers by value.

ManagerLocationValueShares
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$2.6M1,936,760
ARMISTICE CAPITAL, LLCNEW YORK, NY$2.6M1,910,076
VANGUARD GROUP INCValley Forge, PA$468K292,753
OAKTREE CAPITAL MANAGEMENT LPLOS ANGELES, CA$323K241,188
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$309K230,168
JONES FINANCIAL COMPANIES LLLPDES PERES, MO$166K131,789
Man Group plcLONDON, X0$129K96,473
STATE STREET CORPBOSTON, MA$123K92,118
FMR LLCBOSTON, MA$121K90,300
BlackRock, Inc.New York, NY$113K84,282
&PARTNERSNASHVILLE, TN$108K80,864
UBS Group AGZurich, V8$71K52,788
HighTower Advisors, LLCCHICAGO, IL$58K41,000
Oaktree Fund Advisors, LLCLOS ANGLES, CA$58K42,913
NORTHERN TRUST CORPCHICAGO, IL$49K36,313

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$278K0.03%
Oaktree Diversified Income Fund Inc.Oaktree Diversified Income Fund Inc.$5K0.16%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$-12K-0.03%

More